Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Wednesday, 8 January 2020, 16:30 HKT/SGT
Beijing Sciencare Technology Strategically Partners with Hebei's Langfang Government to Jointly Build "Internet + Domestic Precision Care Platform"

HONG KONG, Jan 8, 2020 - (ACN Newswire) - Beijing Sciencare Technology Co., Ltd (the "Company") recently signed a strategic cooperation agreement with the Langfang Municipal Health Commission on the "Internet + Domestic Precision Care Project for Langfang Residents", under which, both parties will be committed to creating a healthy Langfang in order to provide the city's residents with more premium and effective healthcare services.

Through both online and offline healthcare institutes, the internet + domestic precision care platform for Langfang residents adopts technologies including wearable medical devices, big data analysis of images, exact service matching algorithms and artificial intelligence to import quality health services and resources from the Jingjinji Metropolitan Region, China and even the whole world over into Langfang, which will offer Langfang residents precisive domestic healthcare management and care services, enabling 4.6 million Langfang residents to have their health issues resolved locally and making healthcare services truly accessible. Currently, the platform mainly serves senior citizens, children and post-surgery patients living in Langfang, as well as chronic patients such as those suffering from hypertension, cardiovascular diseases, chronic kidney diseases and psychiatric illnesses.

Li Zheng, the Company's founder and director, said "The integration of technology and medical is constantly expanding the room for imagination in the healthcare sector. This time, the cooperation with the Langfang government would be a small step where the Company leverages its technical strengths to add on the Healthy China 2030 Strategies. Going forward, the Company will focus on improving the efficiency of its medical services and bolstering its health services to provide Langfang residents with more precisive products and services based on big data and artificial intelligence."

As part of the strategic cooperation, the Company will promote and operate China's first cloud platform on healthcare compliance services, which will develop into a significant part of the "Langfang Model" and be gradually adopted nationwide. Prior to that, the Company's health compliance services cloud platform already runs online and offers health institutes in China with management services covering external parties' entry, suppliers and healthcare professionals through the application centering on medical compliance services of mobile internet, cloud computing, big data and blockchain technology.

In this collaboration between the Company and Langfang Municipal Health Commission, the introduction of the cloud platform on health compliance services not only offers healthcare institutes in Langfang compliance management services and helps establish the entry threshold for providing domestic precisive care services, but also allows the qualification verification and service quality evaluation of healthcare workers in Langfang, safeguarding the "internet + domestic precision care service" project to be jointly implemented by both parties.

About Beijing Sciencare Technology Co., Ltd
Founded in March 2018 and established a joint venture and reached a strategic partnership agreement with medical technology platform IntelliCentrics Global Holdings Ltd. in November of the same year, Beijing Sciencare Technology Co., Ltd is the health technology business pioneering in developing a healthcare credit system in China and is committed to providing patients with genuine and reliable healthcare services.

About IntelliCentrics (Stock Code: 6819.HK)
With a mission to use trust to make high-quality healthcare as accessible as a good cup of coffee, IntelliCentrics created the SEC^3URE Ethos. Built on three core principles - transparency, neutrality and independence, the SEC^3URE Ethos is relied on by more than 11,000 locations worldwide to ensure two-way trust between patients, doctors, vendor representatives and healthcare companies. To learn more about the world's largest trusted healthcare technology platform, visit IntelliCentrics is publicly traded on the Hong Kong Stock Exchange under the stock code 6819.

Jan 8, 2020 16:30 HKT/SGT
Topic: Press release summary
Sectors: Daily Finance, Daily News
From the Asia Corporate News Network

Copyright © 2020 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

Latest Press Releases
DOCOMO to Partner with AI-powered Enterprise Meeting Note Provider in Japan  
Jan 22, 2020 11:21 HKT/SGT
DOCOMO to Pursue Collaboration with Skydio, U.S. Manufacturer of Autonomous Drones Capable of Flying without GPS Guidance  
Jan 22, 2020 11:00 HKT/SGT
Asia-Pacific had a Record Year for Clinical Trials says Novotech CRO  
Jan 22, 2020 10:40 HKT/SGT
SHIFT RED next gen Drone System creates New Style in U.S marketplace  
Jan 22, 2020 05:00 HKT/SGT
Mitsubishi Motors concludes a disaster cooperation agreement for the first time in Tokyo with Minato City  
Jan 21, 2020 19:04 HKT/SGT
HKTDC Education & Careers Expo opens early February  
Jan 21, 2020 19:00 HKT/SGT
Suprema unveils its Latest Facial Recognition Solution at INTERSEC 2020  
Jan 21, 2020 18:00 HKT/SGT
Invest Hong Kong of the Hong Kong Special Administrative Region Government assists record number of overseas and Mainland companies setting up or expanding in Hong Kong  
Jan 21, 2020 15:30 HKT/SGT
Invest Hong Kong assists record number of Overseas and Mainland Companies setting up or expanding in Hong Kong  
Jan 21, 2020 15:30 HKT/SGT
DOCOMO and DOCOMO ASIA to Provide IoT Solution for YANMAR's SMARTASSIST System in India  
Jan 21, 2020 15:13 HKT/SGT
More Press release >>
More >>
 News Alerts
Copyright © 2020 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 6859 8575

Connect With us: